Section 01
What it's used for
Backed by trials for skin health
Reviews of clinical trials found that oral collagen peptides — usually 2.5-10 g/day for 8-12+ weeks — significantly improved skin hydration, elasticity and wrinkle depth versus placebo. A 2023 review (26 trials, 1,700+ people) confirmed it.
▸Clinical wording
Meta-analyses of randomized controlled trials show that oral collagen peptide supplementation, generally in the 2.5-10 g/day range for roughly 8-12 weeks or longer, significantly improves skin hydration and elasticity and reduces wrinkle depth compared with placebo. A 2023 meta-analysis pooling 26 RCTs and over 1,700 participants confirmed these improvements were statistically significant. However, no source reports a specific magnitude such as a 15-20% improvement in elasticity; the meta-analyses establish statistical significance without quantifying that percentage.
Studied for joint pain relief
Clinical studies show reduced joint pain, especially in athletes, and improved symptoms in people with osteoarthritis — a joint disease from wear and tear on cartilage — when taking about 10 grams of collagen peptides per day.
▸Clinical wording
Studies show reduced joint pain (especially in athletes) and improved symptoms in osteoarthritis with 10g/day.
Studied for bone density with calcium
Clinical trials found that taking collagen peptides together with calcium and vitamin D increased bone mineral density and reduced markers of bone loss, meaning blood signs that bone is being broken down faster than the body can rebuild it.
▸Clinical wording
Clinical trials demonstrate increased bone mineral density and reduced bone loss markers with collagen + calcium/vitamin D supplementation.
Studied for nails and hair
Studies found improved nail growth rate and reduced nail brittleness, meaning less breaking and splitting, along with enhanced hair thickness and faster hair growth in people taking collagen peptides as a daily oral supplement.
▸Clinical wording
Improved nail growth rate and reduced brittleness. Enhanced hair thickness and growth.
Section 02
Mechanism of Action
How collagen fragments enter the blood
- Volunteers who swallowed gelatin hydrolysate went from almost no collagen fragments in blood to measurable levels within two hours.
- Gut wall enzymes trim the three-part fragment, and a transporter (PEPT1) carries the leftover pair into gut cells.
- In mice, 95 percent of an oral dose was absorbed within twelve hours.
- In those mice, labelled material in cartilage was more than double that of the plain-proline comparison.
▸Clinical wording
Intestinal release and absorption of hydroxyproline dipeptides
Healthy volunteers who ingested 9.4–23 g of gelatin hydrolysate from porcine skin, chicken feet or cartilage went from negligible baseline peptide-form hydroxyproline in plasma to 20–60 nmol/mL at 1–2 h (Iwai 2005). Porcine brush-border membrane vesicles clarify the step: the collagen tripeptide Gly-Pro-Hyp is partly trimmed by membrane-bound aminopeptidase N, and the resulting dipeptide Pro-Hyp is carried into the epithelial cell by the H+-coupled transporter PEPT1 (Aito-Inoue 2007). In mice, 95% of an enteral gelatin hydrolysate dose was absorbed within 12 h, and cartilage radioactivity was more than twice that of the free-proline control (Oesser 1999).
A fragment that wakes repair cells
- The proline-hydroxyproline pair (Pro-Hyp) is the most abundant collagen fragment in blood, clearing within a day.
- In mouse skin samples it increased the number of repair cells migrating out and growing on collagen gel.
- Only one marked subset of repair cells takes it up, and the receptor involved is still unidentified.
- Calf serum used in laboratories carries the same fragments, which masks the effect unless it is removed.
▸Clinical wording
Pro-Hyp as a growth signal for p75NTR-positive fibroblasts
Pro-Hyp is the most abundant collagen peptide in human plasma after ingestion, near half of the total, reaching around 100 µM and returning to baseline within 24 h. At 200 nmol/mL it increased the number of fibroblasts migrating out of mouse skin explants and dose-dependently enhanced their growth on collagen gel (Shigemura 2009). The response is selective: only p75NTR-positive fibroblasts, a mesenchymal-stem-cell-marked population that appears at wound sites, take up FITC-labelled Pro-Hyp and proliferate, and the receptor mediating this is still unidentified (Sato 2020). Fetal bovine serum itself carries 70–100 µM hydroxyprolyl peptides, which masks the effect unless removed (Asai 2019).
The only known receptor route so far
- In adult mouse tendon cells the fragment acted through a surface anchor protein (α5β1-integrin).
- It raised the activity of an internal growth signal (ERK1/2) about sixfold after twenty-four hours.
- Treated tendon cells moved more, showed tendon markers and laid down better-organised type I collagen.
- Whether the same route operates in skin repair cells has not been shown.
▸Clinical wording
α5β1-integrin outside-in signalling and ERK activation
The one receptor-level route identified so far comes from adult mouse Achilles tendon cells. Pro-Hyp at 200–500 µg/mL was taken up with linear kinetics over roughly 30 minutes and acted through α5β1-integrin outside-in signalling, raising ERK1/2 (p42/44 MAPK) phosphorylation about sixfold at 24 h through a MEK1/2-dependent step. Downstream, tenocytes and tendon progenitor cells showed increased chemotaxis, lamellipodia-driven motility, tendon differentiation markers and better-organised type I collagen networks (Ide 2021). Whether the same integrin route operates in dermal fibroblasts has not been shown.
Cartilage cells and conflicting results
- Cow cartilage cells in culture secreted more type II collagen as the hydrolysate dose rose.
- Whole collagen and non-collagen protein mixtures did not do this, which argues for a fragment-specific signal.
- In samples of human arthritic cartilage none of three hydrolysates raised collagen making, and two lowered it.
- One sharply raised cartilage-cutting enzymes, though no extra collagen or proteoglycan loss was measurable.
▸Clinical wording
Chondrocyte type II collagen output and cartilage accumulation
Mature bovine chondrocytes cultured with collagen hydrolysate secreted more type II collagen in a dose-dependent way, an effect not reproduced by native collagens or by non-collagen protein hydrolysates, which argues for a peptide-specific feedback signal rather than an amino-acid supply effect (Oesser 2003). The picture is not uniform. In explants of human osteoarthritic articular cartilage none of three bovine hydrolysates stimulated collagen biosynthesis, two inhibited it, and one sharply raised MMP-1, MMP-3 and MMP-13, although without measurable extra collagen or proteoglycan loss (Schadow 2013).
Building versus breaking down tissue
- Rats fed hydrolysate for four weeks had more skin collagen than rats fed a casein diet.
- The same rats had less of one collagen-cutting enzyme (MMP-2), while another (MMP-9) was unchanged.
- In culture, hydrolysates raised bone-building cell activity and lowered bone-removing cell activity as the dose rose.
- Ovary-removed mice fed hydrolysate for twelve weeks had denser bone and a lower bone-breakdown marker in blood.
▸Clinical wording
Matrix protease balance and osteoblast-osteoclast coupling
Four weeks of dietary collagen hydrolysate in young male Wistar rats raised skin type I and type IV collagen on immunoblot versus a casein reference diet and lowered both the proenzyme and active forms of MMP-2 on zymography, while MMP-9 activity was unchanged (Zague 2011). In bone, hydrolysates of bovine, porcine or fish origin at 0.2–1.0 mg/mL increased osteoblast activity dose-dependently and reduced osteoclast activity in culture; ovariectomised mice fed 25 g/kg hydrolysed collagen for 12 weeks had higher bone mineral density and lower serum CTX (Guillerminet 2010).
Section 03
Biological Pathways
- PepT1-mediated intestinal absorptionCollagen hydrolysate raises plasma peptide-form hydroxyproline within 1 to 2 hours; brush-border aminopeptidase N trims Gly-Pro-Hyp, and the resulting Pro-Hyp dipeptide is carried into epithelial cells by PEPT1.
- p75NTR fibroblast growth signalPro-Hyp is the most abundant plasma collagen peptide after ingestion, reaching around 100 micromolar; it increased fibroblast migration and growth on gel, taken up selectively by p75NTR-positive fibroblasts.
- Alpha5beta1-integrin and ERKIn mouse Achilles tendon cells, Pro-Hyp acted through alpha5beta1-integrin outside-in signaling, raising ERK1/2 phosphorylation about sixfold via a MEK1/2-dependent step and increasing tenocyte chemotaxis.
- Matrix and bone remodeling balanceDietary collagen hydrolysate raised skin type I and IV collagen and lowered MMP-2 in rats; in bone, hydrolysates raised osteoblast and lowered osteoclast activity, raising bone density in ovariectomised mice.
Section 04
Dosage Information
| Route / system | Context | Range studied | Limitation |
|---|---|---|---|
| Oral — skin trials | Randomised trials, branded bovine hydrolysate, women 35–65 | 2.5 g a day for 8 weeks in the eye-wrinkle trials; 2.5 g against 10 g a day for 12 weeks — about 28–36 and 110–140 mg/kg at 70–90 kg | A 2025 review of 23 trials found the skin effect only in industry-funded and low-quality studies — not in independent trials of high quality. |
| Oral — joint trials | Knee and hip osteoarthritis, hydrolysed collagen | 10 g a day for 8 weeks to 6 months — about 110–140 mg/kg at 70–90 kg; the largest trial: 10 g daily, 250 people, 24 weeks | The benefit sat with those whose joints were worst damaged and who ate the least meat protein. In the wider population it stays contested. |
| Oral — undenatured type II collagen | Knee osteoarthritis and healthy volunteers, UC-II | 40 mg a day for 90–180 days — about 0.4–0.6 mg/kg at 70–90 kg, roughly 250 times below the hydrolysate joint dose | It works by training the gut to tolerate whole type II collagen, not by supplying amino acids — it is not a smaller hydrolysate dose. |
| Oral — muscle and body composition | Strength training, men with muscle loss and untrained men | 15 g a day for 12 weeks alongside three supervised training sessions a week — about 170–210 mg/kg at 70–90 kg | The placebo group trained too and still gained 2.9 kg of lean mass against 4.2 kg on collagen. Nothing separates it from any other protein. |
| Oral — absorption studies | Blood levels in healthy adults after a single dose | Collagen fragments in blood peak at 20–60 nmol/mL 1–2 h after a dose and halve by 4 h; what circulates is Pro-Hyp and Gly-Pro-Hyp | A blood level, not a dose. Only short fragments and free amino acids get through, so claims tied to the source animal or collagen "type" outrun digestion. |
Section 05
Protocols
- Protocol 01
Joint & Cartilage Recovery
Protocol combining BPC-157, TB-500, and collagen for joint pain, osteoarthritis, and cartilage repair.
- Focus
- Healing & Recovery
- Level
- Intermediate
- Duration
- 8–12 weeks
- Protocol 02
Collagen Beauty Protocol
Comprehensive collagen protocol for skin, hair, nails, and joint health.
- Focus
- Skin & Beauty
- Level
- Beginner
- Duration
- 2–3 months
Section 06
Stability & Storage
Storing the product
Collagen peptides are highly stable as a dry powder and are kept at room temperature in a cool, dry place. The powder has a shelf life of 2+ years and is heat-stable up to 80°C. It is soluble in water and mixes readily into beverages without gelling.
After opening
Once the container is opened, the powder continues to be kept in a cool, dry place, since moisture exposure is what most affects a stable dry peptide powder. The container is generally kept tightly closed between uses to help preserve the stated 2+ year shelf life. Its water solubility and resistance to gelling remain unchanged once opened.
Section 07
Side Effects & Precautions
The safety information reported for collagen peptides covers clinical trial data, a digestive complaint in some users, and a reaction tied to its animal source.
Safety findings in clinical trials
In the clinical trials conducted, no significant adverse effects were reported.
Digestive discomfort in some users
Minor digestive discomfort, including bloating and a feeling of fullness, occurs in some users.
Allergic reactions tied to the source animal
Rare allergic reactions can occur in people allergic to the animal the collagen is sourced from.
Section 08
Regulatory Status
No drug regulator evaluates them for efficacy before sale; oversight instead runs through food-safety and labelling law, and it differs by source and by country.
FDA / United States
Generally Recognized as Safe (GRAS)
Hydrolyzed collagen from bovine, porcine and fish sources is typically self-affirmed GRAS by the manufacturer under 21 CFR 170, without a mandatory FDA review. Sold as food or as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA) of 1994, it needs no pre-market approval.
EU
Not Novel Food when conventionally sourced
Regulation (EU) 2015/2283 requires pre-market authorisation only for foods with no significant history of consumption before 15 May 1997. Collagen peptides hydrolysed from bovine, porcine or fish sources predate that cutoff, so ordinary products need no separate EFSA opinion; collagen made by newer processes, such as egg-membrane extraction, has needed individual Novel Food authorisation.
Claims boundary
Efficacy claims aren't reviewed before sale
Manufacturers may make structure/function claims such as "supports skin elasticity" without pre-market proof, provided the product carries the standard FDA disclaimer that the statement has not been evaluated by the agency. Claims that promise to "stimulate collagen production" or remove wrinkles have drawn FDA warning letters as unapproved drug claims.
WADA
Not on the Prohibited List
Dietary collagen peptides are a structural food protein, not a peptide hormone or growth factor, so they are not restricted under category S2 for competing athletes.
This status covers collagen sold as a conventional protein ingredient; a highly purified fraction, a new extraction process, or a product marketed to treat a specific disease would be assessed differently. Regulatory status differs between jurisdictions and can change — check the current rules of your own regulator.
Section 09
Research Studies
- [1]Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysatesIwai K, Hasegawa T, Taguchi Y, et al. · Journal of Agricultural and Food Chemistry · 2005
- [2]Transport of a tripeptide, Gly-Pro-Hyp, across the porcine intestinal brush-border membraneAito-Inoue M, Lackeyram D, Fan MZ, et al. · Journal of Peptide Science · 2007
- [3]Oral administration of 14C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL)Oesser S, Adam M, Babel W, Seifert J. · The Journal of Nutrition · 1999
- [4]Effect of prolyl-hydroxyproline (Pro-Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skinShigemura Y, Iwai K, Morimatsu F, et al. · Journal of Agricultural and Food Chemistry · 2009
- [5]Food-derived collagen peptides, prolyl-hydroxyproline (Pro-Hyp), and hydroxyprolyl-glycine (Hyp-Gly) enhance growth of primary cultured mouse skin fibroblast using fetal bovine serum free from hydroxyprolyl peptideAsai TT, Oikawa F, Yoshikawa K, et al. · International Journal of Molecular Sciences · 2019
- [6]Collagen-derived di-peptide, prolylhydroxyproline (Pro-Hyp): a new low molecular weight growth-initiating factor for specific fibroblasts associated with wound healingSato K, Asai TT, Jimi S. · Frontiers in Cell and Developmental Biology · 2020
- [7]The dipeptide prolyl-hydroxyproline promotes cellular homeostasis and lamellipodia-driven motility via active beta1-integrin in adult tendon cellsIde K, Takahashi S, Sakai K, et al. · Journal of Biological Chemistry · 2021
- [8]Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagenOesser S, Seifert J. · Cell and Tissue Research · 2003
- [9]Collagen metabolism of human osteoarthritic articular cartilage as modulated by bovine collagen hydrolysatesSchadow S, Siebert HC, Lochnit G, et al. · PLoS ONE · 2013
- [10]Collagen hydrolysate intake increases skin collagen expression and suppresses matrix metalloproteinase 2 activityZague V, de Freitas V, da Costa Rosa M, et al. · Journal of Medicinal Food · 2011
- [11]Hydrolyzed collagen improves bone metabolism and biomechanical parameters in ovariectomized mice: an in vitro and in vivo studyGuillerminet F, Beaupied H, Fabien-Soule V, et al. · Bone · 2010
Section 10
Frequently Asked Questions
A 2023 meta-analysis pooling 26 randomised trials and over 1,700 participants found statistically significant improvements in skin hydration, elasticity and wrinkle depth with 2.5 to 10 g a day for roughly 8 to 12 weeks or longer, versus placebo. A more recent 2025 review of 23 trials complicates that: it found the skin benefit only in industry-funded and lower-quality studies, not in independent, high-quality ones. No source gives a specific figure like "15-20% more elastic" — that number doesn't appear in the underlying research.
In knee and hip osteoarthritis trials, 10 g a day for 8 weeks to 6 months reduced joint pain, including in the largest trial (250 people, 24 weeks). The benefit concentrated in people whose joints were already the most damaged and who ate the least meat protein; in the broader population the effect stays contested rather than settled.
Clinical doses range from 2.5 g a day (skin, 8 weeks) up to 10-15 g a day (joints, strength-training studies), typically sustained for 8 weeks to several months. A different ingredient, undenatured type II collagen, uses a much smaller 40 mg dose, but it works by training gut tolerance to whole collagen rather than supplying amino acids — it isn't a scaled-down hydrolysate dose.
Clinical trials describe an excellent safety profile: minor gastrointestinal discomfort such as bloating or fullness in some users, and rare allergic reactions in people sensitised to the source animal (bovine, porcine, marine or poultry). No significant adverse effects were reported across the trials reviewed.
No data — safety specifically in pregnancy or while breastfeeding was not covered in the material reviewed. Collagen peptides are classified as GRAS (Generally Recognized as Safe) for food use as a dietary supplement, but that status reflects food-ingredient use, not clinical testing in pregnant or breastfeeding people.
No — as a dry powder it is stable at room temperature in a cool, dry place, with a stated shelf life of 2 or more years and heat stability up to 80°C. The main concern is moisture, so the container is kept tightly closed between uses.
Improved nail growth rate and reduced brittleness, along with enhanced hair thickness and growth, are listed among collagen peptides' research applications, but the material reviewed doesn't give trial sizes, doses or effect sizes for these outcomes the way it does for skin and joints — the evidence here is thinner and less specific.